Telehealth Insomnia Prescribing: What Prescribers Can Do in Georgia

If you’re a psychiatrist or PMHNP considering telehealth insomnia care, you’re probably wondering: Can I legally prescribe sleep medications remotely? What about controlled substances like Ambien? Do the rules differ by state?

The short answer: Yes, psychiatrists can prescribe insomnia medications via telehealth nationwide, including controlled substances, as long as you’re licensed in the patient’s state and follow current DEA flexibilities (extended through December 31, 2025). For PMHNPs, the answer is more nuanced—your prescribing authority depends heavily on your state’s scope of practice laws.

This guide walks through everything you need to know: scope differences between MDs and NPs, state-by-state telehealth regulations, controlled substance rules, reimbursement realities, and how platforms like Klarity Health eliminate the patient acquisition headache.

What Psychiatrists and PMHNPs Can Do for Insomnia via Telehealth

Psychiatrists (MD/DO): Full Authority Nationwide

As a board-certified psychiatrist, you have unrestricted prescribing authority for insomnia treatment in all 50 states—no supervision required, no special restrictions beyond holding an active medical license where your patient is located.

What you can do via telehealth:

• Conduct comprehensive insomnia evaluations (video visits meet standard of care)
• Prescribe any FDA-approved sleep medication, including Schedule IV controlled substances (zolpidem, eszopiclone, temazepam)
• Manage comorbid conditions (anxiety, depression) that contribute to insomnia
• Coordinate care with primary care providers or refer for sleep studies when needed
• Provide ongoing medication management with flexible follow-up schedules

The reality: Telehealth has eliminated geographic barriers. You can see a patient in rural Pennsylvania from your home office in Pittsburgh, or serve underserved areas of Texas while maintaining your California license. The only hard requirement is licensure in the patient’s state—though the Interstate Medical Licensure Compact (IMLC) makes multi-state licensing much faster for physicians in member states like Texas and Illinois.

PMHNPs: State-Dependent Authority

Psychiatric Mental Health Nurse Practitioners face a patchwork of state regulations that dramatically affect their ability to independently manage insomnia cases.

Full Practice States (27 states + DC as of 2025):In states like Colorado, Arizona, and Maryland, experienced PMHNPs can evaluate, diagnose, and prescribe insomnia medications completely independently—no physician oversight required. You function essentially like a psychiatrist within your scope of certification.

Reduced Practice States (California, New York, Illinois):These states require collaboration initially but offer pathways to independence:

• New York: After 3,600 practice hours (~2 years full-time), you can practice independently with no written collaborative agreement required. Before that threshold, you need a collaborating physician but minimal day-to-day supervision.

• Illinois: Complete 4,000 clinical hours plus 250 CE hours in your specialty to qualify for Full Practice Authority. Until then, you prescribe under a collaborative agreement with physician delegation.

• California: AB 890 created a transition pathway—work as a ‘103 NP’ in a physician group for 3 years, then become a ‘104 NP’ eligible for full independent practice by 2026. This means some California PMHNPs are already practicing independently for psych conditions including insomnia.

Restricted Practice States (Texas, Florida, Pennsylvania):These states impose the most limitations:

• Texas: You must have a Prescriptive Authority Agreement with a Texas physician that includes monthly quality meetings and chart reviews. You can prescribe Schedule IV sleep meds (Ambien, Lunesta) under delegation, but Schedule II drugs cannot be prescribed in outpatient settings by NPs at all—though this rarely affects insomnia care.

• Florida: Psychiatric NPs were explicitly excluded from the state’s 2020 ‘autonomous practice’ law. You need a supervising physician and written protocol. Additionally, Florida limits NPs to a 7-day supply on any Schedule II controlled substance, and only psychiatric NPs can prescribe psychiatric meds to minors.

• Pennsylvania: Perhaps the most restrictive—you need collaborative agreements with two physicians (not just one), and state law caps Schedule IV prescriptions at 90 days before requiring physician re-evaluation. For ongoing insomnia treatment, this means frequent physician touchpoints.

Bottom line for NPs: Check your state’s current rules carefully. If you’re in a restricted state and joining a telehealth platform, ask whether they provide supervising physician arrangements—many do to enable NP practice compliance.

Free consultations available with select providers only.

Grow your practice on Klarity

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Start seeing patients

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Telehealth Prescribing Rules: Controlled Substances and Compliance

The Federal Landscape (DEA Rules)

Here’s where it gets practical. Most insomnia medications—zolpidem (Ambien), eszopiclone (Lunesta), temazepam (Restoril)—are Schedule IV controlled substances. Historically, the Ryan Haight Act required an in-person exam before prescribing any controlled substance via telemedicine.

COVID changed everything. The DEA suspended this requirement during the public health emergency and has repeatedly extended the flexibility. As of early 2026, providers can prescribe controlled substances via telehealth without a prior in-person visit through December 31, 2025, with the DEA indicating further extensions or permanent rulemaking are coming.

What this means for your practice:

• You can initiate a new patient on zolpidem during their first telehealth visit—no need to see them in person first
• Follow-up medication management visits can all be done remotely
• You must still meet standard clinical documentation requirements and conduct an appropriate audio-visual evaluation
• Audio-only (phone) visits generally don’t meet the standard of care for initiating controlled substances, though some states allow audio-only for established patients in mental health

Coming changes to watch: The DEA is expected to finalize permanent telemedicine prescribing rules. Potential scenarios include requiring at least one in-person visit annually for patients on long-term controlled substances, or mandating a special ‘telemedicine DEA registration.’ Stay updated through your state medical or nursing board, but for now, the regulatory environment is telehealth-friendly.

State-Specific Telehealth Requirements

Licensure is non-negotiable: You must hold an active, unrestricted license in the state where the patient is physically located during the telehealth visit. Period. Telemedicine doesn’t bypass state licensing.

However, some states have made this easier:

• Florida allows out-of-state providers to register as a ‘telehealth provider’ without full Florida licensure if you hold an unrestricted license elsewhere and meet specific criteria (no recent discipline, etc.). This registration lets you treat Florida patients remotely.

• Texas recently passed HB 1052 (effective January 2026) compelling insurers to cover telehealth from out-of-state locations—but you still need a Texas license and address in Texas. It’s more about coverage parity than waiving licensure.

• IMLC states (including Texas, Illinois) offer physicians expedited licensing through the Interstate Medical Licensure Compact, making multi-state practice more feasible. The APRN Compact for nurse practitioners is coming but not yet operational as of 2026.

Prescription Drug Monitoring Programs (PDMPs):Nearly every state mandates checking the PDMP before prescribing controlled substances. For example:

• Texas requires PDMP checks for benzodiazepines and barbiturates
• New York mandates checking the I-STOP database for every Schedule II-IV controlled prescription
• California requires registration in CURES and checking every four months for ongoing controlled prescriptions

Multi-state telehealth providers need access to each state’s PDMP system—plan for the administrative overhead of maintaining multiple logins or delegating to staff.

Florida’s unique controlled substance telehealth rule: Florida prohibits prescribing Schedule II drugs via telehealth except when treating psychiatric disorders, inpatient care, hospice, or nursing homes. Since insomnia is a psychiatric/behavioral condition, you’re explicitly permitted to prescribe Schedule II meds if clinically indicated—though most insomnia drugs are Schedule IV anyway.

Reimbursement: Getting Paid for Telehealth Insomnia Care

What You’ll Actually Earn

Medication management visits for insomnia are typically 15-30 minutes and billed using standard E/M codes:

• CPT 99213 (20-minute established patient visit): ~$95 Medicare national average
• CPT 99214 (30-minute visit): ~$125 Medicare national average

Private insurers generally pay at or above Medicare rates. The key question: does telehealth pay the same as in-person?

Telehealth Payment Parity:As of late 2025, 24 states plus DC have laws requiring private insurers to reimburse telehealth at the same rate as in-person visits. This includes high-volume states like:

• Illinois (permanent payment parity law enacted 2021)
• California (parity mandated since 1996)
• New York (coverage and cost-sharing parity)
• Texas (coverage parity, with 2026 expansion)

What parity means for you: A 30-minute virtual insomnia follow-up in these states pays the same $125-150 you’d get for an office visit. No financial penalty for practicing remotely.

Medicare telehealth: Medicare reimburses tele-mental health visits at the same rate as in-person and has repeatedly extended pandemic-era flexibilities. There’s been discussion of requiring an annual in-person visit for ongoing tele-mental health, but enforcement has been delayed. For now, expect Medicare to pay fairly for remote insomnia care.

The Economics of Patient Acquisition

Here’s where traditional practice models break down—and where platforms like Klarity make financial sense.

The DIY marketing reality:If you’re trying to build a telehealth insomnia practice from scratch, you’re looking at significant upfront costs:

• SEO: Takes 6-12 months of consistent investment (blog content, website optimization, backlinks) before generating meaningful patient flow. Budget $1,500-3,000/month for an agency or hundreds of hours doing it yourself.

• Google Ads: Mental health keywords cost $15-40+ per click. Most clicks don’t convert. When you factor in campaign testing, optimization, and conversion rates, a realistic cost per booked patient through PPC is $200-400+—not the $30-50 you might see quoted in unrealistic marketing materials.

• Directory listings: Psychology Today charges monthly fees and you compete with hundreds of providers on the same page. Zocdoc charges $35-100+ per booking plus monthly subscription fees.

• Total reality: Most solo providers spend $3,000-5,000/month on marketing with uncertain results, especially in the first 6-12 months. Factor in staff time to handle leads, qualify patients, manage no-shows from cold leads, and failed campaigns—true patient acquisition cost is often $300-500+ per qualified psychiatric patient.

The Klarity alternative:Platforms like Klarity Health use a pay-per-appointment model. You pay a standard listing fee per new patient lead (similar to Zocdoc’s per-booking model), but with critical differences:

Value propositions that matter:

• Pre-qualified patients: Leads are already matched to your specialty and availability—no wasted time on unqualified inquiries
• No upfront marketing spend: Zero monthly subscription fees or ad budget gambling
• Built-in telehealth infrastructure: No separate platform costs for video, scheduling, or EHR
• Both insurance and cash-pay flow: Diversified patient revenue streams
• You control your schedule: Only pay when you actually see patients—guaranteed ROI vs uncertain marketing spend

Economic framing: Instead of spending $4,000/month hoping to generate 10-15 new patients through DIY marketing (with no guarantee), you pay only when a qualified patient books. For providers starting out or scaling, this removes financial risk entirely.

Can DIY marketing eventually work? Yes—if you have the budget, expertise, and 12+ months of patience. But for most psychiatrists and PMHNPs, especially those balancing clinical work, a platform that handles patient acquisition makes more sense than becoming a marketing expert.

State-by-State Breakdown: What You Need to Know

California

NP Scope: Transitioning to independence via AB 890. By 2026, experienced PMHNPs can practice fully independently as ‘104 NPs.’

Telehealth: Strong parity laws, CURES PDMP required. High patient demand in underserved Central Valley and Inland Empire regions. Tech-savvy patient base embraces app-based sleep solutions.

Market: Significant psychiatrist shortage despite large provider numbers. Employer-provided tele-mental health benefits common. Privacy compliance (CPRA) required but reputable platforms handle this.

Texas

NP Scope: Restricted—supervising physician required with monthly quality meetings. Can prescribe Schedule IV insomnia meds under delegation; Schedule II prohibited in outpatient settings.

Telehealth: HB 1052 (Jan 2026) improves coverage for out-of-state telehealth. IMLC member for physician licensing. PDMP checks mandatory for benzos.

Market: Massive underserved rural areas (West Texas, Panhandle). Metro areas (Houston, Dallas, Austin) have demand despite competition. Cultural shift post-pandemic toward telehealth acceptance.

Florida

NP Scope: Restricted—psych NPs excluded from autonomous practice law. Need supervising physician. 7-day limit on Schedule II; psychiatric NPs required for pediatric psych meds.

Telehealth: Out-of-state provider registration available. Schedule II prescribing via telehealth allowed for psychiatric use. E-prescribing mandatory for controlled substances.

Market: Large elderly population (careful hypnotic use needed). Long wait times for psychiatrists create opportunity. Spanish-speaking providers in high demand.

New York

NP Scope: Independent practice after 3,600 hours. Newer NPs need collaborative agreement. I-STOP PDMP mandatory for every controlled Rx.

Telehealth: Coverage and cost-sharing parity. Medicaid covers audio-only mental health. Not an IMLC state (separate licensing needed).

Market: NYC tech-savvy demand plus upstate underserved areas. Academic medical centers create referral networks. Strong regulatory support for telehealth.

Pennsylvania

NP Scope: Most restrictive—two-physician collaborative agreement required. 90-day limit on Schedule III/IV before physician re-evaluation.

Telehealth: No comprehensive parity law yet, but insurers generally cover. IMLC member for physicians. Over 500,000 residents in mental health shortage areas.

Market: Significant rural access gaps in central/northern PA. Pittsburgh and Philadelphia have provider concentration but demand exceeds supply.

Illinois

NP Scope: Reduced practice with FPA pathway—4,000 hours + 250 CE to practice independently. Until then, collaborative agreement required.

Telehealth: Permanent payment parity law (2021). IMLC member for physicians. APRN Compact enacted but not yet active.

Market: Chicago hub plus underserved downstate regions. State supports tele-mental health grants. High demand beyond metro area.

The Clinical Reality: How Insomnia Care Differs

Treating insomnia via telehealth isn’t just depression management with different meds. Key differences:

Behavioral therapy is first-line: Unlike conditions where medication is standard first-line treatment, insomnia guidelines emphasize CBT-I (Cognitive Behavioral Therapy for Insomnia) before or alongside medications. You’ll coordinate referrals to therapists or digital CBT-I programs.

Short-term prescribing focus: Chronic pharmacotherapy for insomnia carries risks (tolerance, dependence, next-day impairment). Unlike treating hypertension where medication is lifelong, you’re often prescribing for weeks to months while addressing underlying causes.

Unique side effect monitoring: Sleep-walking, sleep-driving, falls in elderly patients, daytime cognitive impairment—these require careful patient education and follow-up.

Diagnostic complexity: Telehealth insomnia evaluations may require ruling out sleep apnea, restless legs syndrome, or circadian rhythm disorders—sometimes necessitating in-person sleep studies or specialist referrals.

Medication options expanding: Beyond traditional hypnotics, newer agents like orexin receptor antagonists (suvorexant, lemborexant) offer non-addictive alternatives. Off-label options (low-dose doxepin, trazodone) are commonly used.

Typical workflow:

1. Initial 30-45 minute video evaluation: sleep history, psychiatric screening, medical comorbidities review
2. Often request 2-week sleep diary before starting meds
3. If medication indicated: discuss risks/benefits, e-prescribe
4. Follow-up in 2 weeks to assess efficacy and side effects
5. Ongoing management: monthly check-ins, tapering when appropriate, coordinating with therapy

The telehealth format actually enhances care in some ways—you can observe the patient’s home environment during video visits (cluttered bedroom? Bright screens at night?), and flexible scheduling improves adherence to follow-ups.

FAQ: Insomnia Prescribing via Telehealth

Can I prescribe Ambien (zolpidem) during a first telehealth visit with a new patient?

Yes, under current DEA flexibilities extended through December 31, 2025. You must conduct an appropriate audio-visual evaluation and document informed consent. Audio-only (phone) visits generally don’t meet the standard of care for initiating controlled substances. Check your state’s PDMP before prescribing.

What happens after the DEA’s current extension expires?

The DEA is expected to finalize permanent telemedicine rules. Possible scenarios include requiring an annual in-person visit for ongoing controlled substances or a special tele-prescribing registration. Many stakeholders expect extensions will continue given high tele-mental health utilization. Monitor DEA announcements and your state board for updates.

Do I need separate licenses for each state where I see telehealth patients?

Yes. You must be licensed in every state where your patients are located during visits. The Interstate Medical Licensure Compact (IMLC) helps physicians get multi-state licenses faster—Texas and Illinois are members. Some states (like Florida) offer telehealth provider registration for out-of-state clinicians. The APRN Compact for nurse practitioners is coming but not yet active.

What’s the difference between prescribing insomnia meds vs. ADHD or anxiety meds via telehealth?

From a regulatory standpoint, all are controlled substances (typically Schedule IV for insomnia and anxiety; Schedule II for ADHD). Current DEA flexibilities allow prescribing any controlled substance via telehealth. Clinically, insomnia treatment emphasizes short-term use and behavioral therapy, whereas ADHD typically requires long-term medication. State restrictions sometimes specifically address stimulants (Texas NPs can’t prescribe Schedule II outpatient; Florida limits Schedule II to 7-day initial supply).

How do I handle patients who request benzodiazepines for insomnia?

Benzodiazepines (temazepam, triazolam) are effective but carry higher dependence risk than non-benzodiazepine hypnotics (zolpidem, eszopiclone). Guidelines recommend reserving them for short-term use or when non-benzos have failed. Via telehealth, document your clinical reasoning thoroughly, check PDMP for concurrent prescriptions, and establish clear expectations about duration and tapering plans. Many providers prefer starting with non-benzo options or off-label alternatives like low-dose doxepin (3-6mg) which isn’t controlled.

Can PMHNPs in restricted states like Texas or Florida still do telehealth insomnia care?

Yes, but you need a supervising physician arrangement. Many telehealth platforms employ or contract physicians specifically to provide required supervision and delegation agreements for NPs in restricted states. Ask platforms whether they provide this infrastructure—it shouldn’t be your burden to find a collaborating doc in every state you practice.

How often should I follow up with telehealth insomnia patients?

Initial follow-up typically at 2 weeks after starting a new medication to assess efficacy and side effects. For ongoing management, monthly check-ins are common, especially for controlled substances (state PDMP rules may require periodic re-evaluation). As sleep improves, you can extend intervals to quarterly or coordinate tapering. Telehealth’s convenience actually improves adherence to these frequent touchpoints.

What reimbursement codes should I use for insomnia medication management visits?

Most commonly CPT 99213 (20-min established patient visit, ~$95) or 99214 (30-min visit, ~$125). If you provide psychotherapy in addition to medication management (e.g., discussing sleep hygiene, cognitive restructuring), you can use add-on codes (90833 for 16-37 min therapy + med management), though documentation requirements are strict. Pure med management typically uses E/M codes.

Do I need malpractice insurance that specifically covers telehealth?

Most malpractice carriers now include telehealth in standard policies without extra premiums. Verify your policy covers all states where you practice. If you’re adding telehealth to an existing practice, notify your carrier and list additional states. Premiums are generally the same as in-person practice—insurers recognize telehealth as standard care now, especially in psychiatry.

What if a patient needs a sleep study or has undiagnosed sleep apnea?

If your evaluation raises red flags for sleep apnea (loud snoring, witnessed apneas, excessive daytime sleepiness, obesity), refer to their primary care provider or a sleep specialist for polysomnography. You can continue managing psychiatric contributions to insomnia while coordinating with specialists. Telehealth doesn’t limit your ability to order appropriate tests or coordinate care—it just means you can’t perform the in-person physical exam yourself.

Why Joining a Telehealth Platform Makes Financial Sense

Let’s be honest about the economics. Building a private telehealth insomnia practice from scratch means:

• 6-12 months before SEO generates leads
• $3,000-5,000/month in marketing spend with no guaranteed ROI
• Learning Google Ads, content marketing, directory optimization, and lead nurturing—skills unrelated to clinical care
• Absorbing the cost of failed campaigns, no-shows from cold leads, and unqualified inquiries

The alternative: platforms like Klarity Health that handle patient acquisition, credentialing, telehealth technology, and scheduling, letting you focus on clinical work.

What to look for in a platform:

• Transparent per-appointment pricing (not hidden monthly fees that eat into revenue whether you see patients or not)
• Pre-qualified patient matching to your specialty and availability
• Both insurance and cash-pay options for revenue diversification
• Supervising physician support if you’re an NP in a restricted state
• Schedule control—you decide availability; no forced minimums
• Built-in compliance (HIPAA-compliant video, e-prescribing, documentation)

The Klarity model specifically:Klarity uses a pay-per-appointment structure where you pay a listing fee per new patient lead. Compare that to DIY marketing:

For psychiatrists and PMHNPs focused on clinical excellence rather than becoming marketing experts, this is the smart economic choice. You get guaranteed ROI—pay only when you see patients—versus gambling thousands on uncertain marketing channels.

Next Steps: Start Seeing Insomnia Patients via Telehealth

The regulatory environment for telehealth insomnia prescribing is as favorable as it’s ever been—and likely to remain so given national mental health access needs. Current DEA flexibilities allow remote prescribing of controlled substances through at least late 2025, with permanent rules expected to maintain telehealth access.

For psychiatrists, you have full authority nationwide to manage insomnia cases remotely. Your only barriers are state licensure and implementing compliant workflows (PDMP checks, documentation, informed consent).

For PMHNPs, your path depends on your state’s scope of practice laws. In full or reduced practice states (California, New York, Illinois), you can build substantial autonomy. In restricted states (Texas, Florida, Pennsylvania), you’ll need supervising physician arrangements—but telehealth platforms often provide this infrastructure.

The market opportunity is real: insomnia affects 30-40% of adults at some point, psychiatric wait times are measured in weeks to months in many markets, and telehealth eliminates geographic barriers to reach underserved populations.

Rather than spending months building marketing expertise and burning cash on uncertain patient acquisition, consider joining an established telehealth platform like Klarity Health. You’ll get immediate access to pre-qualified patients seeking insomnia treatment, built-in compliance infrastructure, and payment only when you deliver care—no financial risk, no marketing headaches, just clinical work.

Ready to explore how Klarity can connect you with insomnia patients while you focus on what you do best—providing excellent psychiatric care? Learn more about joining Klarity’s provider network and start seeing telehealth patients on your schedule.

References

1. California Board of Registered Nursing – AB 890 Implementation. Retrieved from https://www.rn.ca.gov/practice/ab890.shtml. Updated 2024 (per SB 1451 amendments). Official state board guidance on California’s new NP categories (103/104) and timeline for independent practice (2023-2026).

2. Texas Medical Board – Advanced Practice Registered Nurse Prescribing and Supervision FAQs. Retrieved from https://www.tmb.texas.gov/resources/for-applicants-and-licensees/prescribing-and-supervision. Current as of 2019 law, accessed February 2026. Outlines Texas requirements for prescriptive authority agreements and Schedule II prescribing restrictions.

3. Center for Connected Health Policy (CCHP) – State Telehealth Laws and Reimbursement Policies Report, Fall 2025. Retrieved from https://www.cchpca.org/resources/state-telehealth-laws-and-reimbursement-policies-report-fall-2025/. Published October 2025. Comprehensive state-by-state analysis of telehealth coverage and payment parity laws.

4. USA Doctor Network – How to Get Insomnia Prescriptions via Telemedicine. Retrieved from https://usadocnetwork.com/how-to-get-insomnia-prescriptions-via-telemedicine-3. Published June 11, 2025. Details DEA’s extension of telemedicine prescribing flexibilities through December 31, 2025.

5. Medicare Physician Fee Schedule. Retrieved from https://www.medfeeschedule.com. Effective January 1, 2025 and January 1, 2026. National average reimbursement rates for CPT codes 99213 (~$95) and 99214 (~$125) based on CMS official fee schedule.

Source:

• https://www.nursepractitioneronline.com/articles/nurse-practitioner-practice-authority-updates/#:~:text=As%20of%202025%2C%20the%20distribution,toward%20greater%20autonomy%20for%20NPs
• https://www.nursepractitionerlicense.com/nurse-practitioner-licensing-guides/limitations-of-practice-as-a-nurse-practitioner-in-illinois/#:~:text=physician
• https://www.tmb.texas.gov/resources/for-applicants-and-licensees/prescribing-and-supervision#:~:text=Do%20I%20need%20to%20have,to%20a%20prescriptive%20authority%20agreement
• https://commonwealthfoundation.org/research/nurse-practitioner-reform-full-practice-authority-pennsylvania/#:~:text=expansive%20prescriptive%20authority%20is%20essential,survey%20of%20members%20of%20the
• https://www.rivkinrounds.com/2022/04/new-law-allows-experienced-nps-to-practice-independently-in-ny/#:~:text=New%20York%E2%80%99s%202023%20state%20budget%2C,practice%20without%20a%20collaborative%20relationship
• https://www.nursepractitionerlicense.com/nurse-practitioner-licensing-guides/limitations-of-practice-as-a-nurse-practitioner-in-illinois/#:~:text=With%20sufficient%20experience%2C%20however%2C%20CNPs,250%20additional%20continuing%20education%20units
• https://www.rn.ca.gov/practice/ab890.shtml#:~:text=In%20September%202020%2C%20Governor%20Gavin,Chapter%20481%2C%20Statutes%20of%202024
• https://www.tmb.texas.gov/resources/for-applicants-and-licensees/prescribing-and-supervision#:~:text=match%20at%20L153%20For%20a,meetings%20must%20at%20a%20minimum
• https://www.npschools.com/blog/guide-to-np-practice-in-florida#:~:text=%E2%80%9CUnder%20HB%20607%2C%20psychiatric,%E2%80%9D
• https://usadocnetwork.com/how-to-get-insomnia-prescriptions-via-telemedicine-3#:~:text=Recent%20regulatory%20updates%20have%20introduced,evaluations%20until%20December%2031%2C%202025